Dr. Saveen Semage re-appointed as CEO of NMRA
The Ministry of Health announced the re-appointment of Dr. Saveen Semage as the new Chief Executive Officer (CEO) of the National Medicines Regulatory Authority (NMRA) today (January 09).
Dr. Saveen Semage previously served as the CEO of the NMRA from November 2021 until May 2022, before he resigned from the position.
In May 2022, Dr. Saveen Semage announced his resignation as the CEO of NMRA on social media, blaming the move by Ravi Kumudesh, President of the College of Medical Laboratory Science, over allegations leveled at NMRA over the drug shortage at that time.
The new appointment was made by Health Minister Dr. Ramesh Pathirana, following a selection process from among applications submitted for the vacant position.
Latest Headlines in Sri Lanka
- IMF third review talks with Sri Lanka successfully conclude November 22, 2024
- Professor Gomika Udugamasooriya appointed Senior Advisor to President on Science and Technology November 22, 2024
- Lohan Ratwatte’s wife further remanded until December 2, 2024 November 22, 2024
- Excavation begins near Veyangoda to uncover reported treasure November 22, 2024
- Thai vets plan to trim tusks of Muthu Raja, elephant repatriated from Sri Lanka November 22, 2024